Anthracycline as second line chemotherapy (CT) for metastatic breast cancer (MBC) patients previously treated with taxotere (TXT)

被引：0
|
作者：
Delecroix, V
Fumoleau, P
Perrocheau, G
Azli, N
Fety, R
Priou, F
Maugard, C
Riva, A
Lemevel, B
机构：
[1] CTR RENE GAUDUCHEAU,F-44035 NANTES,FRANCE
[2] RHONE POULENC RORER,ANTONY,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [41] Gemcitabine plus cisplatin combination as second-line treatment in patients with metastatic breast cancer (MBC).
    Ajarim, D
    Ezzat, A
    Bazarbashi, S
    Rahal, M
    El Foudeh, M
    Pai, C
    Raja, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 70S - 70S
  • [42] Use and duration of chemotherapy (CT) in patients (pts) with metastatic breast cancer (MBC) according to tumor subtype (TS) and line of therapy (tx).
    Seah, Davinia Shien
    Luis, Ines Maria Vaz Duarte
    Olson, Erin Macrae
    Sohl, Jessica
    Litsas, Georgia
    Winer, Eric
    Lin, Nancy U.
    Burstein, Harold J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] A single institution randomized trial of taxotere (T) and xelocla (X) given in combination vs. taxotere (t) followed by xelocla (x) after progression as first line chemotherapy (CT) for metastatic breast cancer (MBC)
    Beslija, S.
    Obralic, N.
    Basic, H.
    Tatarevic, A.
    Mahic, N.
    Banjin, M.
    Sosevic, A.
    Ceric, T.
    Pasic, A.
    Salkic, B.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 114 - 114
  • [44] Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes
    Chen, Lan
    Yan, Xi
    Luo, Ting
    Tian, Tinglun
    He, Ping
    Zhong, Xiaorong
    [J]. CANCER MEDICINE, 2024, 13 (10):
  • [45] Sequential administration of docetaxel (D) (Taxotere™) followed by AC in first line metastatic breast cancer (MBC) patients (pts):: Final results
    Antoine, EC
    Chollet, P
    Monfardini, S
    Sorio, R
    Ambrosini, G
    Benhammouda, A
    Mazen, MF
    Ramazeilles, C
    Azli, N
    Khayat, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 19 - 20
  • [46] Phase II study of weekly paclitaxel and carboplatin followed by oral navelbine in patients with triple negative metastatic/recurrent breast cancer previously treated with adjuvant anthracycline and taxotere.
    Halim, Inas Ibraheim Abdel
    El-Sadda, Wael
    El-Ebrashy, Mostafa
    El Ashry, Mohamed
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Taxol and fluorouracil as second line chemotherapy for metastatic breast cancer
    Fornasiero, A
    Ghiotto, C
    Daniele, O
    DAmanzo, P
    Aversa, SML
    Sileni, VC
    Fiorentino, MV
    [J]. BREAST, 1997, 6 (05): : P917 - P917
  • [48] Biweekly paclitaxel combined with cisplatin in the treatment of metastatic breast cancer (MBC) previously treated with anthracyclines
    Donat, Dragutin A.
    Pesic, Jasna
    Muzikravic, Ljubomir
    Trifunovic, Jasna
    Zivanovic, Aleksandar
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 40 - 40
  • [49] A PROGNOSTIC MODEL IN PATIENTS TREATED FOR METASTATIC GASTRIC CANCER WITH SECOND-LINE CHEMOTHERAPY
    Kanagavel, D.
    Bazin, I
    Narimanov, M.
    Garin, A.
    Tjulandin, S.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 83 - 83
  • [50] A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy
    Kanagavel, D.
    Pokataev, I. A.
    Fedyanin, M. Y.
    Tryakin, A. A.
    Bazin, I. S.
    Narimanov, M. N.
    Yakovleva, E. S.
    Garin, A. M.
    Tjulandin, S. A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (09) : 1779 - 1785
12345